GKB Ophthalmics Ltd (GKB)

Loading page…

GKB Ophthalmics Ltd (GKB) · mywealthgrid

About

GKB Ophthalmics Ltd operates in Medical Equipment & Supplies within the Healthcare sector.

Face value: ₹10

Market cap

₹32 Cr

P/E

1.1×

P/B

0.5×

Dividend yield

ROE

48.1%

ROCE

-1.2%

Debt / equity

0.19

OPM

0.7%

EPS (TTM)

₹58.5

Book value

₹118.6

52-week high

—

52-week low

—

2,011 historical price candles were omitted because the exchange source has not been verified.

₹64.4-2.4%1Y

Quick read

rule-based

Pros

+Revenue CAGR of 15.8% over the last 3 years

Cons

−Thin operating margin of 0.7%
−Weak interest coverage of -0.4×

Research score

Structured signal from quality, growth, valuation and momentum.

59/100

Business quality: 38
Growth: 63
Valuation: 75

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Molbio Diagnostics LimitedMOLBIOMOLBIO	₹17,431 Cr	₹17,844 Cr	₹1,020 Cr	₹262 Cr	25.7%	₹145 Cr	13.6%	23.7%	16.2%	—
Poly Medicure LimitedPOLYMEDPOLYMED	₹16,610 Cr	₹16,952 Cr	₹1,997 Cr	₹461 Cr	23.6%	₹315 Cr	17.1%	14.5%	11%	294
Fischer Medical Ventures LimitedFISCHERFISCHER	₹2,190 Cr	₹2,262 Cr	₹367 Cr	₹50 Cr	14%	₹30 Cr	10.1%	13.6%	8.6%	111
Tarsons Products LimitedTARSONSTARSONS	₹1,752 Cr	₹2,135 Cr	₹441 Cr	₹119 Cr	27.9%	₹11 Cr	3.4%	5%	2.3%	361
Laxmi Dental LimitedLAXMIDENTLLAXMIDENTL	₹1,066 Cr	₹1,066 Cr	₹287 Cr	₹46 Cr	15.6%	₹31 Cr	10.4%	14.7%	12.8%	109
Hemant Surgical Industries LtdHSILHSIL	₹885 Cr	—	₹232 Cr	₹23 Cr	10%	₹18 Cr	7.9%	—	—	—
Fabtech Technologies LimitedFABTECHFABTECH	₹632 Cr	₹675 Cr	₹418 Cr	₹45 Cr	8.5%	₹49 Cr	9.3%	15.5%	12.9%	55
Prevest Denpro LtdPREVESTPREVEST	₹452 Cr	—	₹72 Cr	₹25 Cr	34.4%	₹20 Cr	28.5%	—	—	—
Nureca LimitedNURECANURECA	₹332 Cr	₹333 Cr	₹153 Cr	₹4 Cr	0.1%	₹4 Cr	1.4%	3.3%	1.1%	186
Earkart LtdEARKARTEARKART	₹179 Cr	₹179 Cr	₹54 Cr	₹8 Cr	15.5%	₹5 Cr	9.1%	12.1%	7.7%	243
Choksi Asia LtdCHOKSICHOKSI	₹117 Cr	₹119 Cr	₹11 Cr	₹-2 Cr	13.8%	₹2 Cr	10.8%	18.9%	13.5%	142
Shree Pacetronix LtdSHREEPACSHREEPAC	₹68 Cr	₹71 Cr	₹8 Cr	₹1 Cr	23.5%	₹0 Cr	14%	27.4%	18.9%	385

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	57	71	75	88
COGS	37	45	47	60
Gross profit	20	26	28	29
	18	21	24	28
Operating profit (EBITDA)	2	5	4	1
OPM %	3.4%	6.8%	4.9%	0.7%
Depreciation	3	3	3	3
Interest	2	1	2	2
	2	1	1	1
Profit before tax	-1	2	0	-3
Tax	-0	0	0	0
Tax %	-19.4%	0%	14.3%	7.6%
	-1	2	0	-3
PAT margin %	-1.3%	2.7%	0.2%	-3.4%
EPS (₹)	-1.8	2.5	-0.3	-5.6
EPS adjusted (₹)	-1.8	2.5	-0.3	58.5
Annual report	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity capital	5	5	5	5	5
Reserves	—	58	58	58	55
Minority interest	—	4	4	5	4
	—	12	12	11	11
	—	29	31	34	39
Total equity & liabilities	—	107	110	112	115
	26	24	23	19	18
CWIP	—	1	3	4	4
Investments	—	2	2	2	2
	—	80	82	87	91
Total assets	—	107	110	112	115

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	7	5	-3	4
	-17	-4	1	-2
	3	-2	-2	-2
Net cash flow	-7	-0	-4	1
Free cash flow	1	0	-4	2
CFO / Operating profit %	357.3%	104.5%	-75.3%	740.4%

Compounded sales growth

7 years: —
5 years: —
3 years: 16%
1 year: 17%

Return on equity

7 years: —
5 years: —
3 years: -1%
Last year: -5%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Margins
Gross margin %	34.8%	36.8%	37.2%	32.3%
EBITDA margin %	3.4%	6.8%	4.9%	0.7%
EBIT margin %	-2.1%	3.1%	1.1%	-2.6%
PAT margin %	-1.3%	2.7%	0.2%	-3.4%
Working capital
Receivable days	125	100	134	117
Inventory days	349	307	298	245
Payable days	234	208	183	202
NWC days	240	199	249	160
Leverage
Current ratio	1.94	1.91	2.03	1.89
Debt to EBITDA	6.23	2.42	3.05	20.16
Debt to equity	0.19	0.19	0.18	0.19
Interest coverage	0.6	2.2	1.1	-0.4
Asset turnover	0.53	0.64	0.67	0.77
Return ratios
Return on assets %	-0.7%	1.8%	0.1%	-2.6%
Return on capital employed %	1.7%	4.8%	2.5%	-1.2%
Return on equity %	-1.2%	3.1%	0.2%	-5%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	50.86%	50.88%	50.93%	50.95%	50.95%	50.98%	50.99%	51.06%	51.06%	51.13%	51.13%	51.15%
	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%	1.79%
DII	0.01%	0.01%	0.01%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	47.34%	47.32%	47.27%	47.26%	47.26%	47.23%	47.22%	47.15%	47.15%	47.08%	47.08%	47.06%
No. of shareholders	—	—	—	—	—	—	—	—	2,601	2,661	2,634	2,557

Promoter holding up 0.29 percentage points since Sep 2023.

13 deals · 13 Oct 2021 – 22 Sept 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
22 Sept 2026	DHWAJA COMMODITY SERVICES PRIVATE LIMITED	Bulk	BSE	Sell	31,925	₹73.46	₹0.23 Cr
10 Dec 2024	BRIJENDRA KUMAR GUPTA	Bulk	BSE	Sell	37,625	₹103.68	₹0.39 Cr
29 Apr 2024	COUNTER CYCLICAL INVESTMENTS PRIVATE LIMITED	Bulk	BSE	Sell	79,754	₹136.40	₹1.09 Cr
29 Apr 2024	RAGINI CHETAN MEHTA	Bulk	BSE	Buy	27,869	₹135.89	₹0.38 Cr
29 Apr 2024	RAGINI CHETAN MEHTA	Bulk	BSE	Sell	818	₹132.75	₹0.01 Cr
23 Apr 2024	AMIT KUMAR JAIN HUF	Bulk	BSE	Sell	27,056	₹117.38	₹0.32 Cr
23 Apr 2024	AMIT KUMAR JAIN HUF	Bulk	BSE	Buy	17,056	₹120.26	₹0.21 Cr
10 Apr 2023	SANJIV KUMAR GUPTA	Bulk	BSE	Sell	28,121	₹113.99	₹0.32 Cr
24 Jan 2023	AGARWAL KUMAR RAJ	Bulk	BSE	Sell	29,874	₹173.70	₹0.52 Cr
28 Dec 2022	RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED	Bulk	BSE	Buy	33,419	₹103.63	₹0.35 Cr

1–10 of 13

1 / 2

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. K.G. GuptaExecutive Director-Chairperson-MD
Gurudas SawantChief Financial Officer
Mr. Vikram GuptaNon-Executive - Non Independent Director
Mr. Purushottam S MantriNon-Executive - Independent Director
Mrs. Sandhya Ajit KamatNon-Executive - Independent Director
Mr. Ninad G. KamatNon-Executive - Independent Director
Mr. Cedric LoboExecutive Director
Ms. Pooja BicholkarCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in GKB Ophthalmics Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Credit ratings

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that CRISIL Ratings Limited (" CRISIL Ratings") has migrated the ....27 May 2026 from CRISIL

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Dividend dividend21 Sept 2010 · ex-date₹1.2

1

Board meeting to consider results12 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

13 announcementsExport CSV

28 Sept 2026, 11:42 amInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

22 Sept 2026, 1:23 pmAGM/EGM

Submission Of Minutes Of 44Th Annual General Meeting Of The Company Held On 25Th August 2026.

AGM PDF

26 Aug 2026, 2:30 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

25 Aug 2026, 12:50 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

AGM PDF

14 Aug 2026, 12:22 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

12 Aug 2026, 6:35 pmResult

Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026.

Financial Results PDF

1 Aug 2026, 12:23 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

31 Jul 2026, 4:25 pmCompany Update

Disclosure Of Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015("Listing Regulations'')

General PDF

Date	Category	Subject	Filing
28 Sept 2026, 11:42 am	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
22 Sept 2026, 1:23 pm	AGM/EGM AGM	Submission Of Minutes Of 44Th Annual General Meeting Of The Company Held On 25Th August 2026.

Loading announcements…

GKB Ophthalmics Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Return on equity

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Credit ratings

Events

Dividends1

Board meetings1

Announcements

Not in the F&O segment

Dividends1

Board meetings1

Ratio timeline

Quarterly record

Bulk & block deals

Board and management

No fund holdings on record

Announcements

Annual reports

Credit ratings

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Return on equity

1

1

1

1